Stock Research for KERX

KERX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

KERX Stock Chart & Research Data

The KERX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the KERX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


KERX Due diligence Resources & Stock Charts

The KERX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View KERX Detailed Price Forecast - CNN Money CNN View KERX Detailed Summary - Google Finance
Yahoo View KERX Detailed Summary - Yahoo! Finance Zacks View KERX Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View KERX Trends & Analysis - Trade-Ideas Barrons View KERX Major Holders - Barrons
NASDAQ View KERX Call Transcripts - NASDAQ Seeking View KERX Breaking News & Analysis - Seeking Alpha
Spotlight View KERX Annual Report - CompanySpotlight.com OTC Report View KERX OTC Short Report - OTCShortReport.com
TradeKing View KERX Fundamentals - TradeKing Charts View KERX SEC Filings - Bar Chart
WSJ View Historical Prices for KERX - The WSJ Morningstar View Performance/Total Return for KERX - Morningstar
MarketWatch View the Analyst Estimates for KERX - MarketWatch CNBC View the Earnings History for KERX - CNBC
StockMarketWatch View the KERX Earnings - StockMarketWatch MacroAxis View KERX Buy or Sell Recommendations - MacroAxis
Bullish View the KERX Bullish Patterns - American Bulls Short Pains View KERX Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View KERX Stock Mentions - StockTwits PennyStocks View KERX Stock Mentions - PennyStockTweets
Twitter View KERX Stock Mentions - Twitter Invest Hub View KERX Investment Forum News - Investor Hub
Yahoo View KERX Stock Mentions - Yahoo! Message Board Seeking Alpha View KERX Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for KERX - SECform4.com Insider Cow View Insider Transactions for KERX - Insider Cow
CNBC View KERX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for KERX - OTC Markets
Yahoo View Insider Transactions for KERX - Yahoo! Finance NASDAQ View Institutional Holdings for KERX - NASDAQ


Stock Charts

FinViz View KERX Stock Insight & Charts - FinViz.com StockCharts View KERX Investment Charts - StockCharts.com
BarChart View KERX Stock Overview & Charts - BarChart Trading View View KERX User Generated Charts - Trading View


Latest Financial News for KERX

Why is Keryx (KERX) Down 2.7% Since its Last Earnings Report?
Posted on Sunday June 10, 2018

Keryx (KERX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.


Wired News – Keryx Biopharmaceuticals Shares Results of Clinical Trial for Treating Patients with Advanced Chronic Kidney Disease with Ferric Citrate
Posted on Wednesday May 30, 2018

LONDON, UK / ACCESSWIRE / May 30, 2018 / If you want access to our free research report on Keryx Biopharma, Inc. (NASDAQ: KERX) ("Keryx"), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=KERX as the Company's latest news hit the wire. On May 25, 2018, the Company shared the data from an investigator sponsored clinical trial that showed the impact of the use of ferric citrate in treating patients with advanced chronic kidney disease (CKD). The Company presented the results at the recently-held 55th ERA-EDTA Congress held at Copenhagen, Denmark, from May 24, 2018, to May 27, 2018.


Keryx Pharmaceuticals Announces Upcoming Investor Presentations
Posted on Tuesday May 29, 2018

Keryx Biopharmaceuticals, Inc. (KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced two upcoming investor presentations in New York City. Key Opinion Leader Presentation on Iron Deficiency Anemia in Patients w/Chronic Kidney Disease on Thursday, May 31st at noon Eastern time:  The event will feature a presentation by Glenn Chertow, MD, MPH, Professor of Medicine and Chief, Division of Nephrology at Stanford University School of Medicine. Jefferies Global Healthcare Conference Presentation on Wednesday, June 6th at 3:00 p.m. Eastern time: The Company will be providing a corporate update at the Jefferies Global Healthcare Conference, taking place June 5-8 at the Grand Hyatt Hotel in New York City.


Keryx Biopharmaceuticals Inc (NASDAQ:KERX): Does The Earnings Decline Make It An Underperformer?
Posted on Friday May 25, 2018

When Keryx Biopharmaceuticals Inc’s (NASDAQ:KERX) announced its latest earnings (31 March 2018), I wanted to understand how these figures stacked up against its past performance. The two benchmarks I usedRead More...


Enter a stock symbol to view the stock details.